ClinicalMetric / Countries / Czech Republic / intensive care unit acquired weakness
← 🇨🇿 Czech Republic Trials
🇨🇿 Czech Republic Country × Condition

intensive care unit acquired weakness Clinical Trials in Czech Republic

Active clinical trials for intensive care unit acquired weakness with research sites in Czech Republic. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 1 // Recruiting: 1 // Updated: Daily
Total Trials
1
Recruiting Now
1
Country
🇨🇿 Czech Republic

Active Trials in Czech Republic (1)

NCT05671614
Recruiting

Skeletal Muscle Regeneration in Survivors of Critical Illness: How to Prevent Satellite Cell Failure?

Enrollment
50 pts
Country
🇨🇿 Czech Republic
Charles University, Czech Republic
View Trial →

Frequently Asked Questions

How many intensive care unit acquired weakness clinical trials are active in Czech Republic?
There are currently 1 active clinical trials for intensive care unit acquired weakness with sites in Czech Republic, of which 1 are actively recruiting patients.
How can I join a intensive care unit acquired weakness clinical trial in Czech Republic?
To join a intensive care unit acquired weakness clinical trial in Czech Republic, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Czech Republic directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are intensive care unit acquired weakness trials in Czech Republic?
Active intensive care unit acquired weakness trials in Czech Republic span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Czech Republic Trials → Global intensive care unit acquired weakness Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology